It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
Australia, Case Law, Litigation, Patents, Pharma, Pharmaceutical patent, Plausibility, Sufficiency of disclosure, Validity
A burden to bear – a brief comparison of Lyrica and the test for sufficiency in Australia and UK
-
Nokia v. 3D Icons, European Patent Office (EPO Board of Appeal), 24 February 2010
-
Another decision on SPCs for combination products
-
Lifting the fog
-
The German Law Ratifying the Agreement on a Unified Patent Court is Void
-
CA CI v. SC BU SA, High Court of Cassation and Justice (Inalta Curte de Casatie si Justitie), 14 March 2008
-
Beware of “added matter” in Spain
-
Maximizing Patent Term Adjustment For U.S. Patents
-
Post-filing experimental evidence: how to obtain patents in Brazil?
-
What to remember from the dismissal by the CJEU of Spain’s actions against the unitary patent package?